Download Files:
Adezmapimod (hydrochloride)
$41 – $158
Products Details
Product Description
– Adezmapimod (SB 203580) hydrochloride is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38β2, respectively. Adezmapimod hydrochloride inhibits LCK, GSK3β and PKBα with IC50s of 100-500-fold higher than that for SAPK2a/p38. Adezmapimod hydrochloride is an autophagy and mitophagy activator[1].
Web ID
– HY-10256A
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C21H17ClFN3OS
Citations
– Acta Pharm Sin B. 5 September 2022.|Anal Cell Pathol. 2022 Sep 27;2022:9358583.|Cancer Res. (2022) 82 (10): 1991-2002.|Cell Mol Life Sci. 2018 Jul;75(14):2627-2641.|Cell Mol Life Sci. 2023 Jun 21;80(7):186.|Food Chem X. 15 January 2022, 100211.|Food Sci Anim Resour. Oct 12, 2022.|Front Pharmacol. 2021 May 18;12:644116.|Int J Cancer. 2018 Aug 1;143(3):645-656.|Int J Mol Sci. 2023 Jul 6, 24(13), 11168.|J Exp Clin Cancer Res. 2022 Sep 16;41(1):275.|J Neuroinflammation. 2018 Jun 15;15(1):184.|J Periodontal Res. 2021 Nov 13.|Life Sci. 2021 Dec 21;120258.|Onco Targets Ther. 2021 Oct 22;14:5131-5144.|Research Square Print. 2022 Aug.|Research Square Print. September 20th, 2022.|Respir Res. 2022 Jan 11;23(1):6.|Viruses. 2022, 14(7), 1465.|Viruses. 2022, 14(7), 1485.|AAPS PharmSciTech. 2022 Mar 14;23(3):83.|Acs Biomater Sci Eng. 2021 Jun 10.|Acta Pharmacol Sin. 2017 Aug;38(8):1120-1128.|Acta Pharmacol Sin. 2022 Feb 7.|Acta Physiol (Oxf). 2018 Feb;222(2).|Acupunct Med. 2021 Jul 24;9645284211020766.|Aging (Albany NY). 2022 Aug 5;14(15):6149-6168.|Aging Cell. 2020 Oct;19(10):e13217.|Aging Cell. 2022 Jun 17;e13659.|Aging. 2020 Nov 20;12(23):24208-24218.|Aging. 2021 May 11;13(9):12780-12799.|Aging. 2021 May 6;13(10):13788-13806.|Am J Physiol Cell Physiol. 2018 Aug 1;315(2):C225-C235.|Am J Physiol Cell Physiol. 2022 May 18.|Am J Physiol Cell Physiol. 2023 Sep 18.|Am J Transl Res. 2019 Feb 15;11(2):806-818.|Am J Transl Res. 2020 Feb 15;12(2):478-492.|Am J Transl Res. 2020 Jul 15;12(7):3577-3595. |Ann Transl Med. 2019 Dec;7(23):758.|Antioxidants (Basel). 2022 Mar 31;11(4):682.|Antioxidants (Basel). 2023, Mar 30, 12(4), 838.|Antioxidants. 2021 Jun 29;10(7):1049.|Antioxidants. 2021, 10(3), 443.|Antiviral Res. 2022 Nov 10;105463.|Apoptosis. 2021 Feb 7.|Aquaculture. 2023 Dec 15, 577, 739927.|Aquat Toxicol. 2018 Jun;199:116-126. |Arch Biochem Biophys. 2022: 109486.|Arch Toxicol. 2023 May 6.|Artif Cell Nanomed B. 2019 Dec;47(1):3087-3093.|Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):685-695.|Authorea. 2022.|Autophagy. 2020 Aug;16(8):1413-1435.|Autophagy. 2021 Nov;17(11):3592-3606.|Biochem Bioph Res Co. 2020 Oct 15;531(2):187-194.|Biochem Cell Biol. 2017 Feb;95(1):64-68.|Biochim Biophys Acta Mol Basis Dis. 2022 Feb 15;1868(5):166369.|Biochim Biophys Acta Mol Cell Res. 2021 Jun 17;119083.|Biochim Biophys Acta Mol Cell Res. 2023 Jul 17;119540.|Bioengineered. 2022 Apr;13(4):8747-8758.|Biol Pharm Bull. 2022 May 31.|Biol Trace Elem Res. 2023 Sep 13.|Biomaterials. 2018 Aug;175:19-29.|Biomed Pharmacother. 2018 Oct 3;108:1294-1302.|Biomed Pharmacother. 2019 Dec;120:109489.|Biomed Pharmacother. 2020 Jan;121:109304.|Biomed Pharmacother. 2020 Mar;123:109752.|Biomed Pharmacother. 2020 Sep;129:110384.|Biomed Pharmacother. 2023 Jul 27;165:115231.|Biomed Res Int. 2019 Jul 10;2019:5347804.|Biomed Res. 2017; 28 (8): 3383-3386|Biomedicines. 2020 Nov 9;8(11):485.|Bioorg Med Chem. 2020 Jul 1;28(13):115547|bioRxiv. 2020 Jun.|bioRxiv. 2023 Aug 14.|bioRxiv. 2023 Mar 24.|bioRxiv. 2023 Sep 29.|bioRxiv. January 18, 2022.|Biosci Rep. 2020 May 29;40(5):BSR20193256.|BMC Cancer. 2023 Nov 14;23(1):1108.|BMC Complement Altern Med. 2019 Aug 29;19(1):233.|BMC Complement Med Ther. 2022 Apr 6;22(1):100.|BMC Immunol. 2023 Nov 8;24(1):43.|BMC Pulm Med. 2018 Nov 27;18(1):178.|Br J Pharmacol. 2018 Dec;175(23):4338-4352.|Br J Pharmacol. 2020 Nov;177(22):5046-5062.|Brain Res Bull. 2021 May 25;173:162-173.|Brain Sci. 2023 Jul 11, 13(7), 1058.|Can Respir J. 10 Oct 2022.|Cancer Commun (Lond). 2021 Jan 1.|Cancer Lett. 2017 Feb 16;393:22-32. |Carbohydr Polym. 2019 Dec 1;225:115223.|Cell Commun Signal. 2021 Oct 11;19(1):103.|Cell Death Differ. 2017 Mar;24(3):492-499.|Cell Death Differ. 2019 Nov;26(11):2386-2399. |Cell Death Differ. 2020 Jun;27(6):1938-1951.|Cell Death Dis. 2016 Jun 23;7(6):e2273. |Cell Death Dis. 2021 Jun 2;12(6):570.|Cell Death Dis. 2021 Jun 7;12(6):582.|Cell Death Dis. 2021 Nov 27;12(12):1113.|Cell Death Dis. 2022 Jul 15;13(7):615.|Cell Death Dis. 2022 Nov 23;13(11):987.|Cell Death Dis. 2022 Oct 8;13(10):860.|Cell Death Dis. 2019 Jul 8;10(7):520.|Cell Death Dis. 2019 Mar 15;10(4):255.|Cell Death Discov. 2019 Aug 5;5:125.|Cell J. 2022 Dec 1;24(12):732-740.|Cell Microbiol. 2019 Sep;21(9):e13064.|Cell Mol Immunol. 2022 Nov;19(11):1263-1278.|Cell Mol Immunol. 2023 Jan 5.|Cell Physiol Biochem. 2018;46(5):1779-1792. |Cell Prolif. 2019 Nov;52(6):e12691.|Cell Prolif. 2021 Jan;54(1):e12933.|Cell Rep. 2020 Jan 14;30(2):497-509.e4. |Cell Rep. 2022 Dec 27;41(13):111891.|Cell Rep. 2022 Mar 15;38(11):110520.|Cell Res. 2020 Jul;30(7):574-589.|Cell Signal. 2016 Feb;28(2):81-93.|Cell Signal. 2019 Feb;54:17-26. |Cell Signal. 2020 Mar;67:109522.|Cell Signal. 2021 Jun 2;85:110060.|Cells. 2022 Feb 18;11(4):723.|Chem Biodivers. 2019 Aug;16(8):e1900325.|Chem Biol Interact. 2021 Sep 8;348:109634.|Chem Res Toxicol. 2022 Feb 11.|Chem Sci. 2018 Jan 31;9(10):2674-2689.|Chemosphere. 2020 Oct;256:127038.|Chin Arch Otolaryngol Head Neck Surg. 2016,23(01):49-52.|Chin J Nat Med. 2023 Jan;21(1):36-46.|Chin J Nat Medicines. 2020 Oct;18(10):738-748.|Chin Med. 2021 Jul 19;16(1):58.|China Biotechnology. 2017, 37(12): 40-48.|Chinese Herbal Medicines. 1 September 2022.|Clin Mol Hepatol. 2023 Feb 20.|CNS Neurosci Ther. 2020 Sep;26(9):913-924.|Commun Biol. 2022 Jul 22;5(1):726.|Curr Res Nutr Food Sci. 2023 Jan.|Cytokine. 2021, 155502.|Dev Comp Immunol. 2021 Oct 14;104292.|Diabetes Metab Syndr Obes. 2021 Nov 12;14:4523-4534.|Dis Markers. 2018 Apr 17;2018:7413027.|Drug Dev Res. 2022 Sep 1.|Ecotoxicol Environ Saf. 2020 Mar 1;190:110133.|Ecotoxicol Environ Saf. 2023 Jul 13;263:115247.|Elife. 2016 Apr 11;5:e14087.|EMBO Mol Med. 2022 Dec 13;e16373.|EMBO Rep. 2021 Jul 5;22(7):e51678.|Endocrine. 2020 Apr;68(1):103-115.|Environ Int. 2020 Oct;143:105949.|Environ Pollut. 2020 Jan;256:113375.|Environ Pollut. 2021 Jan 1;268(Pt B):115748.|Environ Pollut. 2022 Oct 1;120234.|Environ Toxicol. 2021 Feb;36(2):276-286.|Environ Toxicol. 2022 Sep 29.|Environ Toxicol. 2023 Jul 19.|Eur Arch Otorhinolaryngol. 2019 Mar;276(3):767-774.|Eur J Pharmacol. 2021 Jun 22;174270.|Eur J Pharmacol. 2021, 173982.|Eur J Pharmacol. 2022 May 16;926:175034.|Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):1-8. |Exp Eye Res. 2023 Jan 15.|Exp Physiol. 2020 Dec 17.|Exp Ther Med. 2020 Mar;19(3):1824-1834.|Exp Ther Med. 2020 Mar;19(3):2243-2251.|Exp Ther Med. 2021 Mar 8.|Exp Ther Med. 2023 Mar 14.|Exp Ther Med. October 12, 2021.|Exp Ther Med. October 20, 2021.|Exp Ther Med. October 28, 2021.|FASEB J. 2019 Feb;33(2):2435-2450. |FASEB J. 2020 Jun;34(6):8442-8458.|FASEB J. 2020 Nov;34(11):14892-14904.|FEBS Open Bio. 2020 Mar;10(3):434-443.|Food Biosci. 2021, 101268.|Food Biosci. 7 May 2022, 101766.|Food Chem Toxicol. 2020 Dec 28;148:111925.|Food Chem Toxicol. 2022: 113550.|Food Chem Toxicol. 2023 Apr 12;176:113784.|Food Chem Toxicol. 2023 Jun 2;113870.|Food Chem X. 2022 Apr 30;14:100321.|Food Funct. 2021 Mar 9.|Free Radic Biol Med. 2017 Nov;112:49-59.|Free Radic Biol Med. 2021 Dec;177:247-259.|Free Radic Biol Med. 2019 Nov 1;143:275-287.|Front Biosci (Landmark Ed). 2023 Dec 1, 28(12), 325.|Front Cell Dev Biol. 2021 Feb 11;9:570451.|Front Cell Dev Biol. 2021 Jun 18;9:659389.|Front Cell Infect Microbiol. 2019 Jul 15;9:253.|Front Endocrinol. 2021 Mar 12;12:629554.|Front Immunol. 2017 Oct 10;8:1278.|Front Immunol. 2018 Dec 7;9:2854.|Front Immunol. 2018 Jun 5;9:1225. |Front Immunol. 2021 Apr 1;12:584097.|Front Immunol. 2021 Jul 28;12:688294.|Front Immunol. 2021 Jul 7;12:692286.|Front Oncol. 2020 Sep 30;10:523577.|Front Pharmacol. 2021 Apr 30;12:644886.|Fundam Clin Pharmacol. 2020 Oct;34(5):591-602.|Genome Biol. 2023 Feb 1;24(1):20.|Glia. 2023 Mar 24.|Haematologica. 2020 Jan;105(1):124-135. |Harvard Medical School LINCS LIBRARY|Hepatology. 2023 Feb 1;77(2):456-465.|Hum Mol Genet. 2017 Sep 15;26(18):3553-3563.|Infect Immun. 2020 Dec 14;IAI.00680-20.|Int Immunopharmacol. 2019 Dec;77:105940.|Int Immunopharmacol. 2019 Jul;72:252-257. |Int Immunopharmacol. 2020 Jun;83:106473.|Int Immunopharmacol. 2020 Nov;88:106823.|Int Immunopharmacol. 2020 Nov;88:106949.|Int Immunopharmacol. 2021 Oct 26;101(Pt A):108264.|Int Immunopharmacol. 2022 Feb 28;107:108643.|Int Immunopharmacol. 2023 May 12;120:110287.|Int J Biochem Cell Biol. 2021, 106003.|Int J Biochem Cell Biol. 2021, 106036.|Int J Biol Macromol. 2020 May 1;150:261-280.|Int J Biol Macromol. 2022 Dec 12;227:45-57.|Int J Biol Sci. 2022 May 1;18(8):3167-3177.|Int J Biol Sci. 2023 Sep 4;19(15):4744-4762.|Int J Clin Exp Med. 2017;10(9):13542-13549.|Int J Mol Med. 2021 Jan;47(1):243-255.|Int J Mol Med. 2023 Aug;52(2):67.|Int J Mol Sci. 2022 Mar 25;23(7):3589.|Int J Mol Sci. 2022 Nov 25;23(23):14730.|Int J Mol Sci. 2022, 23(20), 12219.|Int J Mol Sci. 2022, 23(22), 14141|Int J Mol Sci. 2022, 23(23), 14730|Int J Radiat Oncol Biol Phys. 2022 Dec 16;S0360-3016(22)03519-2.|Invest Ophthalmol Vis Sci. 2020 Jul 1;61(8):28.|J Agric Food Chem. 2018 Jun 27;66(25):6317-6325. |J Agric Food Chem. 2022 Apr 13;70(14):4328-4341.|J Agric Food Chem. 2023 Feb 8.|J Agric Food Chem. 2023 Jun 9.|J Asian Nat Prod Res. 2020 Sep;22(9):850-863.|J Biol Chem. 2019 Apr 19;294(16):6531-6549.|J Cardiothorac Surg. 2021 May 10;16(1):127.|J Cell Biochem. 2018 Nov;119(10):8450-8459.|J Cell Biochem. 2018 Dec 2.|J Cell Biol. 2021 Feb 1;220(2):e201911025.|J Cell Mol Med. 2018 Nov;22(11):5450-5467.|J Cell Mol Med. 2019 May;23(5):3357-3368. |J Cell Mol Med. 2020 Aug;24(16):9300-9312.|J Cell Mol Med. 2020 Sep;24(18):10935-10945.|J Cell Physiol. 2019 Dec;234(12):23302-23314. |J Cell Physiol. 2020 Oct;235(10):6563-6573.|J Clin Endocrinol Metab. 2021 Jan 23;106(2):337-350.|J Clin Neurosci. 2020 Aug;78:365-370.|J Dairy Sci. 2020 Dec;103(12):11636-11652.|J Endod. 2018 May;44(5):751-758.|J Ethnopharmacol. 2021 Jul 24;114414.|J Eur Acad Dermatol Venereol. 2020 Apr;34(4):862-872.|J Exp Clin Cancer Res. 2022 Dec 29;41(1):364.|J Funct Foods. 2019, 103562.|J Immunol Res. 2020 Feb 10;2020:6457879.|J Immunother Cancer. 2018 Dec 18;6(1):151.|J Immunother Cancer. 2019 Jul 12;7(1):178.|J Inflamm Res. 2021 Mar 23;14:1007-1017.|J Integr Agric. 2023 Feb 24.|J Interferon Cytokine Res. 2019 Apr;39(4):224-232. |J Interferon Cytokine Res. 2021 Dec;41(12):439-449.|J Invest Dermatol. 2019 Dec;139(12):2488-2496.e4.|J Invest Dermatol. 2021 Aug 3;S0022-202X(21)01670-5.|J Invest Dermatol. 2022 Apr 11;S0022-202X(22)00272-X.|J Leukoc Biol. 2023 May 26;qiad063.|J Microbiol. 2021 Jun 1.|J Mol Cell Cardiol. 2015 Dec;89(Pt B):268-79. |J Nanobiotechnology. 2022 Mar 27;20(1):162.|J Nanobiotechnology. 2023 Sep 4;21(1):316.|J Neuroinflammation. 2020 Oct 28;17(1):321.|J Neuroinflammation. 2022 Nov 24;19(1):283.|J Neurol Sci. 2020 Mar 15;410:116679.|J Periodontol. 2021 Sep 17.|J Periodontol. 2020 Jan 16.|J Pharm Pharmacol. 2023 Apr 7;rgad027.|J Proteome Res. 2021 Apr 2.|J Transl Med. 2019 Oct 4;17(1):335.|J Vet Med Sci. 2023 May 23.|J Vet Sci. 2023 Sep 4;24(5):e72.|J Virol. 2023 May 31;e0028423.|Life Sci. 2020 Apr 1;246:117396.|Life Sci. 2020 Nov 15;261:118465.|Med Sci Monit. 2020 Aug 7;26:e925298.|Med Sci Monit. 2019 Jun 21;25:4609-4616. |MedComm. 2023 Jul 8;4(4):e320.|Mediators Inflamm. 2020 Nov 3;2020:8925973. |Microb Pathog. 2021 Aug 11;105136.|Microb Pathog. 2021 Sep 30;105219.|Mol Cell Biochem. 2022 Jan 6.|Mol Cell Endocrinol. 2018 Jul 15;470:38-47. |Mol Cell Endocrinol. 2019 Apr 5;485:35-43. |Mol Cell Toxicol (2019) 15:209-219|Mol Cell. 2020 Jan 2;77(1):95-107.e5. |Mol Immunol. 2017 Jul;87:161-170.|Mol Immunol. 2018 Sep 26;103:133-143.|Mol Immunol. 2021 Jan 15;S0161-5890(20)30590-3.|Mol Med Rep. 2019 Nov;20(5):4576-4586.|Mol Med Rep. 2020 Jul;22(1):566-574.|Mol Med Rep. 2021 Oct;24(4):709.|Mol Nutr Food Res. 2019 Dec;63(24):e1900601.|Mol Ther Oncolytics. 5 August 2022.|Molecules. 2022, 27(5), 1577.|Mycopathologia. 2021 Jun 4.|Nanotoxicology. 2020 Jun;14(5):667-682. |Nat Commun. 2018 Apr 30;9(1):1723.|Nat Immunol. 2023 Nov;24(11):1813-1824.|Nat Metab. 2021 Oct 18.|Neural Regen Res. 2022.|Neurochem Int. 12 November 2021, 105221.|Neurochem Res. 2020 Sep;45(9):2052-2064.|Neuropsychiatry (London). 2018;8(4);1132-1139.|Neuroscience. 2021 Jan 6;S0306-4522(20)30826-5.|Nitric Oxide. 8 October 2022.|Npg Asia Mater. (2019) 11:38|Nutr Metab. 2021 Nov 21;18(1):100.|Oncogene. 2017 Apr;36(15):2095-2104.|Oncogene. 2022 Jan 7.|Oncol Lett. 2020 Apr;19(4):3269-3277.|Oncotarget. 2017 Oct 19;8(60):101965-101983.|Oxid Med Cell Longev. 10 Mar 2022.|Oxid Med Cell Longev. 2017;2017:6175841.|Oxid Med Cell Longev. 22 Jun 2022.|Pakistan J Zool. 2023 Nov 17.|Parasit Vectors. 2021 Jul 8;14(1):358.|Patent. US20170349880A1.|Patent. US20180263995A1.|PeerJ. 2023 Aug 23.|Peptides. 2019 Sep;119:170120. |Pharmacol Res. 2018 Jul;133:218-235.|Pharmacology. 2021 Oct 29;1-14.|Phytochemistry. 2020 Dec;180:112531.|Phytomedicine. 2018 Mar 15;42:152-163.|Phytomedicine. 2020 Mar;68:153146.|Phytomedicine. 2020 May 24;75:153247.|Phytomedicine. 2020 Nov;78:153306.|Phytomedicine. 2021, 153479.|Phytomedicine. 5 January 2022, 153928.|Phytother Res. 2022 Oct 17.|PLoS Biol. 2018 May 11;16(5):e2004225. |PLoS One. 2020 Sep 3;15(9):e0235824.|Programa de Doctorado en Biomedicina. 2020 Sep.|Protein Cell. 2019 Mar;10(3):161-177. |Redox Biol. 2023, 102594.|Redox Biol. 30 August 2022, 102452.|Reprod Domest Anim. 2021 May 12.|Research Square Preprint. 2021 Dec.|Research Square Preprint. 2021 Jan.|Research Square Preprint. 2021 May.|Research Square Preprint. 2021 Oct.|Research Square Preprint. 2021 Sep.|Research Square Preprint. 2022 Feb.|Research Square Preprint. 2022 Jan.|Research Square Preprint. 2022 May.|Research Square Preprint. 2023 Nov 10.|Research Square Print. November 15th, 2022|Research Square Print. November 29th, 2022.|Respir Res. 2021 Aug 3;22(1):216.|Respir Res. 2023 Apr 7;24(1):103.|School of Healthcare Science. Manchester Metropolitan University. 2017 May.|Sci Immunol. 2022 Jan 21;7(67):eabj5501.|Sci Rep. 2017 Oct 19;7(1):13571.|Sci Rep. 2022 Feb 23;12(1):3053.|Sci Total Environ. 2023 Aug 25;166449.|Signal Transduct Target Ther. 2020 Aug 25;5(1):163.|Signal Transduct Target Ther. 2022 Jul 11;7(1):222.|SSRN. 2023 May 8.|SSRN. 8 Nov 2021.|Stem Cell Res Ther. 2021 May 20;12(1):295.|Stem Cell Res Ther. 2022 Jan 21;13(1):22.|Stem Cell Rev Rep. 2022 Jan 26.|Stem Cells. 2020 Jan;38(1):134-145.|Stem Cells. 2022 Jun 30;sxac046.|Stem Cells. 2022 May 27;40(5):508-522.|Toxicol Appl Pharmacol. 2019 Mar 1;366:83-95. |Toxicol Appl Pharmacol. 2021 Mar 11;115484.|Toxicol Appl Pharmacol. 2019 Nov 1;382:114703.|Toxicol Lett. 2023 Jul 26;384:73-85.|Toxicology. 2021 Feb 13;152721.|Toxics. 2022, 10(6), 285.|Toxins. 2021 Jun 13;13(6):422.|Toxins. 2022 Jan 1;14(1):29.|Vaccines. 2019 Dec 14;7(4):216.|Vet Microbiol. 2021, 109061.|Vet Res. 2021 Oct 21;52(1):135.|Virology. 2017 Aug;508:150-158.
References
– [1]Lali FV, et al. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. J Biol Chem. 2000 Mar 10;275(10):7395-402.|[2]Davies SP, et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000 Oct 1;351(Pt 1):95-105.|[3]Leelahavanichkul K, et al. A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis. Mol Oncol. 2014 Feb;8(1):105-18.
CAS Number
– 869185-85-3
Molecular Weight
– 413.90
Compound Purity
– 99.71
SMILES
– O=S(C1=CC=C(C2=NC(C3=CC=C(F)C=C3)=C(C4=CC=NC=C4)N2)C=C1)C.[H]Cl
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology; Cancer
Solubility
– DMSO : 100 mg/mL (ultrasonic)|H2O : 5 mg/mL (ultrasonic)
Target
– Autophagy;Mitophagy;p38 MAPK
Isoform
– p38 MAPK;p38β
Pathway
– Autophagy;MAPK/ERK Pathway
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
